Marta
Rodríguez González
Publicaciones (46) Publicaciones de Marta Rodríguez González
2024
-
Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer
International Journal of Molecular Sciences, Vol. 25, Núm. 4
-
Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma
Scientific Reports, Vol. 14, Núm. 1
-
LT and SOX9 expression are associated with gene sets that distinguish Merkel cell polyomavirus (MCPyV)-positive and MCPyV-negative Merkel cell carcinoma
The British journal of dermatology, Vol. 190, Núm. 6, pp. 876-884
-
Survival among treated tongue cancer patients: a single-center experience
Discover Oncology, Vol. 15, Núm. 1
2023
-
Analysis of Circulating Tumor DNA in Synchronous Metastatic Colorectal Cancer at Diagnosis Predicts Overall Patient Survival
International Journal of Molecular Sciences, Vol. 24, Núm. 9
-
Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets
American Journal of Hematology
-
Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers
Cancers, Vol. 15, Núm. 17
-
NanoString analysis of mycosis fungoides reveals individual molecular identity
British Journal of Dermatology
-
The Impact of Liquid Biopsies Positive for EGFR Mutations on Overall Survival in Non-Small Cell Lung Cancer Patients
Diagnostics, Vol. 13, Núm. 14
-
Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma: Beyond Blood Eosinophils
Archivos de Bronconeumologia, Vol. 59, Núm. 8, pp. 502-509
-
siRNA screening reveals that SNAP29 contributes to exosome release
Cellular and Molecular Life Sciences, Vol. 80, Núm. 7
2022
-
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
Journal of Visualized Experiments, Vol. 2022, Núm. 187
-
Dysregulated Expression of Three Genes in Colorectal Cancer Stratifies Patients into Three Risk Groups
Cancers, Vol. 14, Núm. 17
-
PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression
Journal of Investigative Dermatology, Vol. 142, Núm. 5, pp. 1391-1400.e15
-
iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancers
WORLD JOURNAL OF CLINICAL ONCOLOGY, Vol. 13, Núm. 7, pp. 616-629
2021
-
Cómo mejorar la precisión de los diagnósticos I y III del Sistema Bethesda
Revista ORL, Vol. 12, Vol. 4, pp. 313-323
-
Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy
Hemato, Vol. 2, Núm. 2, pp. 281-304
-
Genetic complexity impacts the clinical outcome of follicular lymphoma patients
Blood Cancer Journal
-
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death
Blood, Vol. 137, Núm. 24, pp. 3351-3364
-
Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers
Blood Advances, Vol. 5, Núm. 24, pp. 5588-5598